Mood disorders like major depression and bipolar disorder are among the most studied – and most misunderstood – conditions in mental health. One of the most fundamental questions researchers and clinicians ask is: why do they develop in the first place? The answer is rarely simple. Mood disorders don’t spring from a single cause. Instead, they emerge from a complex interaction of genetic predispositions, environmental pressures, and biological mechanisms that quietly shape how the brain regulates emotion. Understanding these causes – known collectively as the etiology of mood disorders – is essential for anyone who wants to understand the science behind depression and bipolar disorder.
Table of Contents
- Genetic risk factors
- What twin studies tell us
- Neurotransmitter imbalances
- Environmental triggers
- Stressful life events
- Beck’s negative triad and cognitive distortions
- Biological mechanisms: the HPA axis and thyroid abnormalities
- The HPA axis and cortisol dysregulation
- Thyroid abnormalities and depression
- Why etiology matters for treatment
Genetic risk factors
The first place researchers look when trying to understand mood disorders is the family tree. Evidence consistently shows that mood disorders run in families – and the data is striking. According to Harvard Health, half of those with bipolar disorder have a relative with a similar pattern of mood fluctuations. For first-degree relatives of someone with major depression, the risk of developing the condition themselves is 1.5 to 3 times higher than the general population.
What twin studies tell us
Twin studies are one of the most powerful tools for separating genetic from environmental contributions to illness. The logic is straightforward: identical (monozygotic) twins share 100% of their genes, while fraternal (dizygotic) twins share about 50%. If a disorder is largely genetic, we’d expect identical twins to both develop it far more often than fraternal twins – and that is exactly what researchers find for mood disorders.
Stanford Medicine reports that the heritability of major depression is estimated at 40-50%, and may be higher for severe depression. For bipolar disorder, the numbers are even more pronounced. Studies of identical twins show that if one twin has bipolar disorder, the other has a 60-80% chance of developing it too – compared to just 20% for fraternal twins. Research published in Focus places the overall heritability of bipolar disorder at 60-90%, ranking it among the most heritable of all psychiatric conditions.
Critically, concordance among identical twins is never 100%, which confirms that genes alone do not cause mood disorders. Genetic risk creates a vulnerability – but whether that vulnerability translates into a disorder depends heavily on other factors.
Neurotransmitter imbalances
At the neurochemical level, mood disorders are strongly associated with disruptions in brain signaling. The monoamine deficiency hypothesis – one of psychiatry’s most well-known theories – holds that depression involves reduced activity of three key neurotransmitters: serotonin, dopamine, and norepinephrine.
According to a comprehensive review in World Psychiatry, almost every compound that inhibits monoamine reuptake – increasing the concentration of these neurotransmitters in the synaptic cleft – has proven to be a clinically effective antidepressant. This pharmacological evidence forms the backbone of the monoamine deficiency hypothesis.
Each neurotransmitter plays a distinct role. Serotonin is the most extensively studied: experimental reductions in central serotonin have been linked to mood-congruent memory bias, altered reward-related behaviors, and disrupted emotional processing. Dopamine imbalances, on the other hand, are associated with the loss of pleasure – known as anhedonia – where activities that once felt rewarding no longer do. Norepinephrine is believed to affect anxiety, alertness, and the body’s stress response.
That said, more recent research has challenged the simplicity of the “chemical imbalance” narrative. Current evidence increasingly points to depression involving complex dysregulation of multiple neurotransmitter systems, neural circuits, and inflammatory pathways – not just a straightforward shortage of serotonin or dopamine.
Environmental triggers
Genes and brain chemistry don’t operate in a vacuum. Life experiences play a central role in triggering mood disorders, particularly in people who already carry a genetic predisposition. The diathesis-stress model captures this well: a person with a biological vulnerability will be far more likely to develop a mood disorder when confronted with significant environmental stressors.
Stressful life events
Harvard Health notes that stress triggers a cascade of chemical reactions in the body. When that stress is short-lived, the body typically recovers. But when stress becomes chronic, changes in the brain can become long-lasting – setting the stage for depressive episodes. Early losses such as the death of a parent, childhood abuse, neglect, or prolonged trauma have been found to leave individuals measurably more vulnerable to depression later in life.
It’s important to emphasize that most people who experience stressful life events do not develop a mood disorder. Whether someone does depends on their genetic makeup, coping resources, social support, and neurobiological resilience. Stress is a trigger, not a guarantee.
Beck’s negative triad and cognitive distortions
Environmental experiences don’t just cause stress – they can shape how a person thinks. One of the most influential psychological theories linking environment to depression is Aaron Beck’s cognitive triad, proposed in 1967. According to Beck’s model, depression-prone individuals develop dysfunctional attitudes that lead them to process information in a persistently negative manner across three domains:
- The self – viewing oneself as worthless, flawed, or unlovable
- The world – seeing the environment as hostile, overwhelming, and filled with insurmountable obstacles
- The future – believing that nothing will improve and that hopelessness is permanent
Beck theorized that these negative self-schemas often originate in childhood – through experiences of criticism, bullying, loss, or abuse – and become automatic patterns of thought that persist into adulthood. When a stressful life event activates these schemas, the person doesn’t just feel sad; they experience a flood of automatic negative thoughts that feel both uncontrollable and entirely true.
These cognitive distortions – such as overgeneralization (“I always fail”), catastrophizing (“This will ruin everything”), and personalization (“It’s all my fault”) – maintain and deepen the depressive state. Research confirms that the cognitive triad is specifically associated with negative mood and the absence of positive affect, and that all three components – negative views of the self, the world, and the future – tend to be active simultaneously in depressed individuals.
The good news is that because these are learned cognitive patterns, they can be unlearned. Cognitive Behavioral Therapy (CBT), which is built directly on Beck’s framework, has proven effective in identifying and restructuring these distorted thinking patterns.
Biological mechanisms: the HPA axis and thyroid abnormalities
Beyond genetics and psychology, mood disorders have clear biological signatures in the body’s hormonal and neuroendocrine systems. Two of the most studied are the hypothalamic-pituitary-adrenal (HPA) axis and the hypothalamic-pituitary-thyroid (HPT) axis.
The HPA axis and cortisol dysregulation
The HPA axis is the body’s central stress-response system. When a stressor is perceived, the hypothalamus releases corticotropin-releasing hormone (CRH), which signals the pituitary gland to secrete adrenocorticotropic hormone (ACTH), which in turn prompts the adrenal glands to release cortisol – the body’s primary stress hormone. Normally, elevated cortisol feeds back to suppress CRH and ACTH, keeping the system in balance.
In people with depression, this feedback loop breaks down. Research shows that overactivity of the HPA axis occurs in major depressive disorder, resulting in persistently elevated cortisol levels. This chronic hypercortisolemia contributes to cognitive dysfunction, reduced mood, hippocampal shrinkage, and even neuroinflammation. A significant percentage of depressed patients show measurably elevated cortisol in saliva, plasma, and urine – along with enlarged pituitary and adrenal glands, reflecting the sustained overactivation of the system.
Harvard Health also notes that elevated levels of corticotropin-releasing hormone (CRH) are typically found in depressed individuals, and that antidepressants and electroconvulsive therapy both work in part by reducing these high CRH levels. Childhood trauma, in particular, can negatively affect HPA axis functioning for life – one biological pathway through which early adversity increases later vulnerability to depression.
Thyroid abnormalities and depression
The link between thyroid function and mood disorders has been recognized for nearly two centuries. Research confirms that both excess and insufficient thyroid hormones can produce mood abnormalities, including depression – and that these symptoms are often reversible with proper thyroid treatment.
Hypothyroidism (an underactive thyroid) is particularly relevant. Studies have established that serotonin and other neurotransmitters influence the HPT axis, creating a biological bridge between thyroid dysfunction and depression. Undiagnosed or undertreated hypothyroidism significantly raises the risk of developing depression, and is recognized as one of the leading causes of treatment-resistant depression. Thyroid hormones T3 and T4 are essential for normal brain function, mood regulation, and cognition – when their levels are disrupted, mood disorders can follow.
A large systematic review and meta-analysis published in JAMA Psychiatry found a 1.3-fold increased risk of depression across all degrees of hypothyroidism, with the risk rising to 1.77-fold in patients with overt (diagnosable) hypothyroidism. This is why clinicians routinely screen for thyroid abnormalities when evaluating patients presenting with depressive symptoms.
The HPT axis dysregulation also works in the other direction: some depressed patients show a blunted TSH response to thyrotropin-releasing hormone (TRH), suggesting a degree of central hypothyroidism even in the absence of overt thyroid disease. Research published in Frontiers in Endocrinology describes this as a potential form of functional central hypothyroidism in depressed individuals – one more thread connecting the body’s hormonal systems to the experience of persistent low mood.
Why etiology matters for treatment
Understanding the causes of mood disorders isn’t purely academic. It has direct implications for how these conditions are treated. A person whose depression is rooted in HPA axis dysregulation from chronic stress may respond differently to medication than someone whose depression is tied to hypothyroidism or to deep-seated cognitive distortions from early childhood experiences. The most effective treatment approaches – whether medication, therapy, or a combination – often reflect an understanding of which etiological factors are most prominent in a given individual.
Mood disorders are multifactorial. Genes load the gun, neurotransmitter systems pull the trigger, life events provide the pressure, and biological systems like the HPA and HPT axes set the stage. No single cause explains the full picture – which is precisely why these conditions require such careful, individualized understanding.
What do you think? If genetic heritability only accounts for part of the risk for mood disorders, what does that suggest about how much influence our environment and life experiences actually have? And knowing that biological factors like the HPA axis and thyroid function play a role, how might this change how we think about treating depression beyond just addressing psychological symptoms?
References
- https://www.health.harvard.edu/depression/how-genes-and-life-events-affect-mood-and-depression
- https://med.stanford.edu/depressiongenetics/mddandgenes.html
- https://psychiatryonline.org/doi/10.1176/foc.5.1.14
- https://pmc.ncbi.nlm.nih.gov/articles/PMC2950973/
- https://www.medicalnewstoday.com/articles/326090
- https://onlinelibrary.wiley.com/doi/10.1111/jnc.16097
- https://www.sciencedirect.com/topics/psychology/cognitive-triad
- https://www.ebsco.com/research-starters/social-sciences-and-humanities/becks-cognitive-triad
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10272270/
- https://en.wikipedia.org/wiki/Hypothalamic%E2%80%93pituitary%E2%80%93adrenal_axis
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8533829/
- https://journals.sagepub.com/doi/pdf/10.5127/pr.034413
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3246784/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9392461/
- https://www.thyroid.org/patient-thyroid-information/ct-for-patients/april-2022/vol-15-issue-4-p-3-4/
- https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1454744/full
Leave a Reply